Author

Mossa Gardaneh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Farzaneh AfzaliiD· 1 shared Zahra NayeriiD· 1 shared Zarrin MinuchehriD· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Farzaneh AfzaliORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 12, 2019

Investigating the Inhibitory Aspects of Metformin/Curcumin Co-Treatment through Convergence of In-Silico and In-Vitro Approaches

Farzaneh Afzali, Zahra Nayeri, Zarrin Minuchehr, Mossa Gardaneh

This study investigates the inhibitory effects of Metformin and Curcumin co-treatment on breast cancer and DM2 using in-silico and in-vitro methods, identifying shared genes and showing synergistic effects.

DOI 10.1101/568634

humanbulk RNA-seq

𝕏 PostBluesky